If you have been funded or published as a result of consulting with our Service Cores or receiving an Advance RI-CTR award, please remember to cite our grant number: U54GM115677.
Who should acknowledge Advance RI-CTR in research publications?
Everything you need to cite Advance RI-CTR in your research publications.
Everything you need to cite Advance RI-CTR in your research publications.
If you have been funded or published as a result of consulting with our Service Cores or receiving an Advance RI-CTR award, please remember to cite our grant number: U54GM115677.
Who should acknowledge Advance RI-CTR in research publications?
Federal law requires that all NIH-funded investigators submit an electronic version of their final, peer-reviewed manuscript to the National Library of Medicine’s PubMed Central upon acceptance for publication. See the NIH Public Access Policy.
Advance RI-CTR requires all investigators to acknowledge Advance RI-CTR in all of their research publications that benefited from any Advance RI-CTR resources.
Advance RI-CTR requires all investigators to acknowledge Advance RI-CTR in all of their research publications that benefited from any Advance RI-CTR resources.
Faculty who are supported by Advance RI-CTR must acknowledge the grant in all research publications that are related to their role with the grant.
Publications that are unrelated to the faculty member’s funded role with Advance RI-CTR may also be acknowledged. This is encouraged by NIGMS and Advance RI-CTR, but at the discretion of the researcher or faculty member.
“The project described was supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Rhode Island Clinical and Translational Research (Advance RI-CTR). Support from the [INSERT NAME] Core of Advance RI-CTR was received. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
“[INSERT NAME] is partially supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Rhode Island Clinical and Translational Research (Advance RI-CTR). Support from the [INSERT NAME] Core of Advance RI-CTR was received. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
"Acquisition of the [INSERT INSTRUMENT NAME, e.g., NanoString CosMx Spatial Molecular Imager] used in this study was made possible through funding provided by the Institutional Development Award Number U54GM115677 (Advance RI-CTR) from the National Institute of General Medical Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."
"Access to and support of REDCap was provided by the Biomedical Informatics, Bioinformatics, and Cyberinfrastructure Enhancement Core of Advance Rhode Island Clinical and Translational Research (Advance RI-CTR). Use of Advance RI-CTR REDCap was made possible through funding provided by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Advance RI-CTR REDCap also leverages computational resources and services provided by the Office of Information Technology and its Center for Computation and Visualization at Brown University.”
These guidelines reflect NIH policy. Advance RI-CTR staff will monitor publications to assure adherence with these requirements. Failure to comply with the terms and conditions of the Public Access Policy may result in the placement of special conditions on current awards or preclusion of grantees from obtaining future Advance RI-CTR funding.